Restatement of Previously Issued Financial Statements - Condensed Consolidated Statement of Income and Comprehensive Income (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	2 Months Ended	3 Months Ended				5 Months Ended	6 Months Ended
	Jun. 30, 2022	May 26, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	May 26, 2022	Jun. 30, 2022	Jun. 30, 2021
Restatement of Previously Issued Financial Statements
Gain from change in fair value of earnout liability			$ 61,680					$ 61,680
Total other income (expense), net			63,928		$ (421)			63,579	$ (909)
Income (loss) before provision for income taxes			(21,675)		9,839			(12,261)	18,744
Net income (loss)	$ (21,122)		(21,329)	$ 9,350	9,761	$ 8,841		(11,979)	18,602
Less: Net loss attributable to noncontrolling interest	(18,516)	$ (207)	(18,723)				$ 9,143	(9,373)
Net income (loss) attributable to biote Corp.			(2,606)					(2,606)
Comprehensive income (loss)			$ (21,334)		$ 9,771			$ (11,978)	$ 18,603
Net income (loss) per common share
Basic			$ (0.34)					$ (0.34)
Diluted			$ (0.34)					$ (0.34)
As Previously Reported
Restatement of Previously Issued Financial Statements
Gain from change in fair value of earnout liability			$ 123,350					$ 123,350
Total other income (expense), net			125,598					125,249
Income (loss) before provision for income taxes			39,995					49,409
Net income (loss)	40,548		40,341					49,691
Less: Net loss attributable to noncontrolling interest			(75,115)					(65,765)
Net income (loss) attributable to biote Corp.			115,456					115,456
Comprehensive income (loss)			$ 40,336					$ 49,692
Net income (loss) per common share
Basic			$ 15.24					$ 15.24
Diluted			$ 2.01					$ 2.01
Adjustment
Restatement of Previously Issued Financial Statements
Gain from change in fair value of earnout liability			$ (61,670)					$ (61,670)
Total other income (expense), net			(61,670)					(61,670)
Income (loss) before provision for income taxes			(61,670)					(61,670)
Net income (loss)	$ (61,670)		(61,670)					(61,670)
Less: Net loss attributable to noncontrolling interest			56,392					56,392
Net income (loss) attributable to biote Corp.			(118,062)					(118,062)
Comprehensive income (loss)			$ (61,670)					$ (61,670)
Net income (loss) per common share
Basic			$ (15.59)					$ (15.58)
Diluted			$ (2.35)					$ (2.35)